HIGHLIGHTS
- who: Wolfgang Winnicki and collaborators from the Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria have published the research work: Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing, in the Journal: Biomedicines 2022, 10, 2882. of /2022/
- what: The study is intended to provide further evidence on whether individualization of MPA therapy is possible. To compare the baseline variables between the study groups, the Mann-Whitney U test, median test, or Fisher`s exact test was used. A receiver operating characteristic (ROC) analysis was conducted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.